Only RM0.205/share X 200k share.

ESOS at RM0.105/share X 1.8 million share again. Haha… Pattern sama dari dulu.

Cakap senang.

https://www.theedgemarkets.com/article/bioalpha-cancels-covid19-vaccine-deal-sinopharm-unit

For South Sudan, makan pun dah susah and always war. Lagi mau cakap sell Covid-19 test kit and upplement product. Apa la ni......

Mana sales revenue and profit contribution for:
1) CME contract.
2) Ritamix contract.
3) China contract.
4) Covid-19 vaccine.
5) Paling latest, Africaaaaa...... Haha....

Wau.... Malaysia, Indonesia and China haven't make good profit in business. Sudah mau pergi Africa buat business. Apa ini? Haha.....

Learn from William Hon, sell all your RI at RM0.23. At least, making RM0.03.

Betul awak.

Sama-sama share your opinion.

Haha…. Why so serious? No need to sorry. This public forum. You can comment, I can comment.

This quarter will know. If green, will be good. If red, game over and hope for another quarter to be green.

More interested to see contribution from China contract of RM2.1 billion.

Ritamix is kacang puteh for Bioalpha.

Bioalpha and Ritamix have no relationship at all. Ritamix share up, doesn’t mean Bioalpha will up.

1) Mana RM2.1 billion contract from China?
2) Mana Ritamix?
3) Mana CME Group?
4) Mana COVID-19 vaccine?

Wah… Again same tactic.
1) Mana RM2.1 billion contract from China?
2) Mana Ritamix?
3) Mana CME Group?
4) Mana COVID-19 vaccine?
5) Now, tambah RS Unggul? Felda market bigger or China market bigger?

Wong, William is doing a lot since last year until today on ESOS, PP and RI. Haha….

https://www.klsescreener.com/v2/news/view/825571

Lagi lambat result keluar, lagi kuat rugi.

ahfad, don’t BS la… Sometime buy mother, sometime buy son.

Let see how good is 1st Q 2021 report.

Dari dulu, Bioalpha dah macam ini. One day show.

Mother and son price also drop.

Tiu lo.... Kena XOX lagi. Haha...

If RI use in a correct way, then it is good. For example, production capacity expansion for more business. As for Bioalpha, is not good. Not real in business and the net profit is negative for 4 quarter. Seem like Bioalpha is cover CEO, MD and BOD salary only. Haha...

Aiya.... William always BS. Don’t worries, William will always said next 2 quarter is doing better than current quarter. :)

Only know copy and paste la...:

True lo.... So easy to catch those rich guy meh? All talk like super good. Mana evidence?

All also BS how good how good la.... Haha....

William dispose own share and create new share again for himself with cheap price. I strongly believe he is not genuine and no ethic in business.

Now, Bioalpha look very similar to AT, Macpie, Saudee, Komark, Lambo and Fintec.

Even the price up, it can’t sustainable. No big investor company interested. Only operator goreng up and then sell to gain money. Additional, rubbish William and rubbish BOD keep on ESOS, PP, ICPS and RI. Siapa interested?

William and other BOD in Bioalpha is already failure. Always talk how good is China business but result is like shit. Ritamix and CME also a shit.

William untung la.... Beli murah, jual mahal nanti.

The person who want to buy Bioalpha share sure have many opportunity after this PP.

Habis lo.... William PP 290 million share again. He will sell again in the open market.

Morning post, afternoon post, evening post and night also post the same thing. Funny la....

What is this guy trying do? Is he/she losses a lot money in XOX share?

Should be happy mah....

Since everyone also making tonne of huge money, why still quarrel with each other?

Limit up soon, okok...

Abc234567, are you sure Celcom is holding 50% of XOX? Can share some information?

Wau, so many retailers really don’t trust XOX.

Sudah “Chim Sui”.

Where is CME, Ritamix, China contract and COVID-19 vaccine?

Ya, all bad news already out. But the all the good news also never show good result woh.... Ini bad or good news?

Besides, buy low and sell high. Not to be greedy also very important.

Dream more, dream will come true. Haha....

Kawan, ini dunia memang macam ini. Orang makan orang dalam dunia perniagaan.